Onco-Innovations Limited (CSE:ONCO)

Canada flag Canada · Delayed Price · Currency is CAD
1.430
+0.010 (0.70%)
Apr 24, 2025, 10:55 AM EDT
120.00%
Market Cap 71.26M
Revenue (ttm) n/a
Net Income (ttm) -64.37K
Shares Out 50.18M
EPS (ttm) -0.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 30,700
Average Volume 119,592
Open 1.450
Previous Close 1.420
Day's Range 1.400 - 1.450
52-Week Range 0.560 - 2.800
Beta n/a
RSI 39.82
Earnings Date Aug 1, 2025

About Onco-Innovations

Onco-Innovations Limited, a pre-clinical stage biotechnology company, develops drug candidates for cancer treatments. Its lead product candidate is ONC010, a novel inhibitor of the deoxyribonucleic acid repair enzyme polynucleotide kinase 3′-phosphatase in a nanoparticle formulation based on the drug delivery technology. The company is headquartered in Calgary, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Thomas O’Shaughnessy
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ONCO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.